This study was designed to further characterize peripheral skeletal muscle
alterations in patients with chronic obstructive pulmonary disease (COPD) a
nd to evaluate the possible relationship between myosin heavy chain (MyoHC)
isoform expression and exercise tolerance in these individuals.
MyoHC composition from biopsy of the vastus lateralis muscle was examined i
n 12 COPD patients (forced expiratory volume in one second (FEV1)=31+/-9% p
redicted, peak oxygen consumption (V'O-2)=15+/-4 mL.kg(-1).min(-1)) and 10
age-matched normal male subjects (peak V'(O2)=20+/-15 mL.kg(-1).min(-1)).
The proportion of MyoHC type I was smaller in COPD than in normals (27+-17%
ve,sns 41+/-9%, p<0.05) with an increase in MyoHC type IIa (51 +/- 15% ver
sus 39+/-93%, p<0.05) and the proportion of MyoHC type IIx being comparable
between both groups. A significant relationship was found between peak V'O
-2 mL.kg(-1).min(-1) and FEV1% pred (r=0.91, p<0.0001) and the percentage o
f MyoHC type I (r=0.61, p=0.016), In stepwise multiple regression, only FEV
1% pred was found to be a significant determinant of peak V'O-2 (p<0.0001).
This variable explained 83% of the total variance of peak V'O-2.
In summary, this study shon ed considerable modifications in the phenotypic
expression of the myosin heavy chain in the vastus lateralis muscle in pat
ients with chronic obstructive pulmonary disease. An independent effect of
myosin heavy chain expression on exercise capacity was not found. These res
ults suggest that chronic inactivity and muscle deconditioning may not be t
he sole factors explaining peripheral muscle dysfunction in patients with c
hronic obstructive pulmonary disease.